References
- Loebi DH, Craig RM, Colic DD, et al. Gastrointestinal blood loss: effect of aspirin, fenoprofen, and acetaminophen in rheumatoid arthritis as determined by sequential gastroscopy and radioactive fecal markers. JAMA 1977: 237(10): 976–81
- Beirne JA, Biancbine JR, Johnson PC, et al. Gastrointestinal blood loss caused by tolmetin, aspirin, and indomethadn. Clin Pharmacol Ther 1974: 16(5 Pt 1): 821–5
- Ryan JR, McMahon FG, Vargas R, et al. Effects of salsalate, aspirin and naproxen on plasma renin activity (PRA) and platelet thromboxane B2 synthesis. (Abstr) Arthritis Rheum 1986: 29(4): S103
- Mathison DA, Stevenson DD. Hypersensitivity to nonsteroidal antiinflammatory drugs: indications and methods for oral challenges. J Allergy Clin Immunol 1979: 64(6 Pt 2): 669–74
- Homes JL, Winter CA, Sadowuki SJ, et al. Multiple sites on prostaglandin cyclooxygenase are determinants In the action of nonsteroidal antiinflammatory agents. Proc Natl Acad Sci USA 1981: 78(4): 2053–6
- Vane JR. inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature 1971: 231 (25): 232–5
- Pedersen AK, Fitzgerald GA. Dose-related kinetics of aspirin: presystemic acetylation of platelet cyclooxygenase. N Engl J Med 1984: 311(19): 1206–11
- Higgs GA, Harvey EA, Ferreira SH, et al. The effects of anti-inflammatory drugs on the production of prostaglandins in vivo. Adv Prostaglandin Thromboxane Leukotriene Res 1976: 1: 105–10
- Flower RJ, Moncada S, Vane JR. Analgesic-antipyretics and anti-inflammatory agents: drugs used in the treatment of gout. in: Gilman AG. Goodman LS, Rail TW, et al, eds. Goodman and Gilman's the pharmacological basis of therapeutics. 7th ed. New York: MacMillan, 1985: 674–715
- Ferreira SH. Prostaglandins and nonsteroidal anti-inflammatory drugs. Prostaglandins Thromboxanes 1977: 6: 352–61
- Vargaftig B, Lefort J. Acute hypotension due to carrageenan, arachidonic acid and slow reacting substance C in the rabbit: role of platelets and nature of pharmacological antagonism. Eur J Pharmacol 1977: 43(2): 125–41
- Zorier RB, Weissmann G, Haffstein S, et al. Mechanisms of lysosomal enzyme release from human leukocytes, II. Effects of cAMP and cGMP, autonomic agonists, and agents which affect microtubule function. J Clin Invest 1974: 53(1): 297–309
- Orange RP, Austen WG, Austen KF. Immunological release of histamine and slow-reacting substance of anaphylaxis from human lung. I. Modulation by agents influencing cellular levels of cyclic 3′,5′-adenosine monophosphate. J Exp Med 1971: 134(3 Suppl): 136–48S
- Henney CS, Bourne HR. Lichtenstein LM. The role of cyclic 3′,5′ adenosine monophosphate in the specific cytolytic activity of lymphocytes. J Immunol 1971: 107(2): 610–2
- Zorier RB, Quagliata F. Effect of prostaglandin E1 on adjuvant arthritis. Nature 1971: 234(327): 304–5
- Zorier RB, Damjanov L, Miller PL, et al. Prostaglandin E1 treatment prevents progression of nephritis in immune lupus erythematosus. J Clin Lab Immunol 1978: 1: 95–8
- Abramson S, Korchak H. Ludewig R, et al. Modes of action of aspirin-like drugs. Proc Natl Acad Sci USA 1985: 82(21): 7227–31
- Broh-Kahn RH. Choline salicylate: a new. effective, and well-tolerated analgesic, anti-inflammatory. and antipyretic agent. Int Ree Med 1960: 173(Apr): 217–33
- Pierson RN Jn Holt PR, Watson RM, et al. Aspirin and gastrointestinal bleeding: chromate51 blood loss studies. Am J Med 1961: 31 (Aug): 259–65
- Cohen A. Fecal blood loss and plasma salicylate study of salicylsalicylic acid and aspirin. J Clin Pharmacol 1979: 19(4): 242–7
- Cohen A., Garber HE. Comparison of choline magnesium trisalicylate and acetylsalicylic acid in relation to fecal blood loss. Curr Ther Res 1978: 23: 187–93
- Edmar D. Effects of salicylates on the gastric mucosa as revealed by roentgen examination and the gastrocamera. Acta Radiol 1971: 11(1): 57–64
- Cohen A, Thomas GB, Cohen EB. Serum concentration, safety and tolerance of oral doses of choline magnesium trisalicylate. Curr Ther Res 1978: 23: 358–64
- Zocker MB, Rothwell KG. Differential influences of salicylate compounds on platelet aggregation and serotonin release. Curr Ther Res 1978: 23: 194–9
- Estes D, Kaplan K. Lack of platelet effect with the aspirin analog, salsalate. Arthritis Rheum 1980: 23(11): 1303–7
- Simon MR, Salberg DJ, Muller BF, et al. Lack of adverse reactions to salsalate in asthmatic subjects. St Paul: 3M Riker (unpublished report)
- April PA, Corran NJ. Ekholm BP, et al. Multicenter comparative study of salsalate vs aspirin In rheumatoid arthritis. (Abstr) Arthritis Rheum 1987: 30(4): S93